Production of GABA-enriched idli with ACE inhibitory and antioxidant properties using Aspergillus oryzae: the antihypertensive effects in spontaneously hypertensive rats

Food Funct. 2020 May 1;11(5):4304-4313. doi: 10.1039/c9fo02854d. Epub 2020 May 4.

Abstract

The present study aimed to develop a fermented food (idli) with enhanced γ-aminobutyric acid (GABA) and angiotensin I-converting enzyme (ACE) inhibitory properties using a GABA-producing fungus. Aspergillus oryzae NSK fermented idli batter and GABA was maximized (451.7 mg kg-1) in 120 h. The ACE inhibitory, 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) free radical scavenging and nitric oxide radical scavenging activities increased to 41.8%, 1.9 and 0.6 μmol trolox equivalent antioxidant capacity (TEAC) per gram in 120 h, respectively. In contrast, phytic acid and trypsin inhibitor activities decreased to 3.01 g kg-1 and 30.8 mg kg-1, respectively. The systolic blood pressure of spontaneously hypertensive rats in the fermented idli diet group was lower than those fed a plain idli diet. Lipid peroxidation in the plain idli diet group was significantly higher, whereas superoxide dismutase and glutathione reductase activities were significantly lower. The expression of genes ET-1, HSP70, NF-κB and iNOS in the aorta of SHRs that received GABA-containing diets was down-regulated between 2.2 and 3.8 fold. The production of GABA-enriched foods can be a promising approach to lower the blood pressure of spontaneously hypertensive rats.

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / metabolism
  • Animals
  • Antihypertensive Agents / metabolism
  • Aspergillus oryzae / metabolism*
  • Blood Pressure
  • Disease Models, Animal
  • Fermented Foods*
  • Hypertension*
  • Oryza*
  • Phaseolus*
  • Phytotherapy
  • Rats
  • Rats, Inbred SHR
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • gamma-Aminobutyric Acid